Literature DB >> 33532282

Cerebrovascular disease in pregnancy and puerperium: perspectives from neuroradiologists.

Naiwu Wang1, Xudong Shen2, Gang Zhang3, Bo Gao4,5, Alexander Lerner6.   

Abstract

Pregnancy-related cerebrovascular disease is a serious complication of pregnancy and puerperium. The etiology and pathological mechanisms of cerebrovascular disease are complex, involving changes in the cardiovascular, endocrine, and immune systems. Vascular risk factors during pregnancy and puerperium may cause vasospasm and endothelial cell damage leading to cerebral ischemia, hemorrhage, posterior reversible encephalopathy syndrome (PRES), and reversible cerebral vasoconstriction syndrome. Arterial or venous obstruction may damage the blood-brain barrier (BBB) and impede venous return, resulting in cerebral edema, hemorrhage, and intracranial hypertension. Pregnancy with hypercoagulability may threaten the lives of both the mother and the developing fetus. With improvements in stroke treatment during pregnancy and puerperium, neuroradiologists have gained new insights into this problem. This article reviews the pathogenesis, imaging findings, and risk factors of stroke during pregnancy and puerperium, focusing on imaging diagnosis and prognostic assessment. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Cerebrovascular circulation; imaging; pregnancy; puerperium; stroke

Year:  2021        PMID: 33532282      PMCID: PMC7779914          DOI: 10.21037/qims-20-830

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  2 in total

Review 1.  Research progress on the mechanism of cerebral blood flow regulation in hypoxia environment at plateau.

Authors:  Gui-Sheng Hao; Qing-Li Fan; Quan-Zhong Hu; Qian Hou
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 2.  Uncommon Female-Predominant Etiologies of Cryptogenic Stroke.

Authors:  Jing Dong; Xin Ma
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.